News & Updates
Filter by Specialty:
INCREASE OLE data reflect long-term benefit of inhaled treprostinil for PH-ILD
Findings from the open-label extension (OLE) phase of the INCREASE study boost the efficacy and safety of inhaled treprostinil for pulmonary hypertension due to interstitial lung disease (PH-ILD).
INCREASE OLE data reflect long-term benefit of inhaled treprostinil for PH-ILD
31 May 2022
MS patients on certain DMTs may have limited protection from COVID-19 vax
The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.
MS patients on certain DMTs may have limited protection from COVID-19 vax
30 May 2022
SARS-CoV-2 antigen tests exhibit moderate-to-high sensitivity vs RT-PCR, cultures
Home antigen tests for SARS-CoV-2 infection were moderately sensitive compared with RT-PCR* test but highly sensitive compared with viral culture in adults and children with RT-PCR-confirmed infection, a prospective study suggests.
SARS-CoV-2 antigen tests exhibit moderate-to-high sensitivity vs RT-PCR, cultures
26 May 2022
Long COVID: What factors contribute to the risk?
Only a minority of patients are considered fully recovered 1 year after being discharged from hospital due to COVID-19, with women and obese individuals at increased risk of long COVID, according to results of the prospective PHOSP-COVID* study presented at ECCMID 2022 and published in The Lancet.
